Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
3.140
+0.220 (7.53%)
At close: Nov 26, 2025, 4:00 PM EST
3.189
+0.049 (1.55%)
After-hours: Nov 26, 2025, 7:40 PM EST
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $113.35 million as of November 26, 2025. Its market cap has increased by 104.55% in one year.
Market Cap
113.35M
Enterprise Value
105.14M
1-Year Change
104.55%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $113.35M, a decrease of -9.06%. That is a compound annual growth rate of -2.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 113.35M | 97.83% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |